The Psychopharmacology of Huperzine A: an Alkaloid with Cognitive Enhancing and Neuroprotective Properties of Interest in the Treatment of Alzheimer´s Disease | Debio 9902 - ZT-1 | /

Home|Careers|Contact us

News

20.11.2008
Debiopharm and Aurigene sign licensing agreement for the development and commercialisation of Debio 0617, a novel inhibitor of an undisclosed oncology pathway
17.11.2008
Debiopharm and Pharmaleads sign license agreement for Debio 0827 or PL37 in treatment of chronic pain conditions

The Psychopharmacology of Huperzine A: an Alkaloid with Cognitive Enhancing and Neuroprotective Properties of Interest in the Treatment of Alzheimer´s Disease

Andrea Zangara

Pharmacology Biochemistry and Behavior, Volume 75, Issue 3, June 2003, Pages 675-686